Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$104.74
+0.85%
Mkt Cap $9.59B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (30 analysts)
$111.82
Range $80.00 – $130.00
Implied Upside
+6.8%
Consensus $111.82 vs current $104.74
NASDAQ·Healthcare·Biotechnology
$104.74
+0.85%
Mkt Cap $9.59B
Buy
17
Hold
0
Sell
0
Price Target (30 analysts)
$111.82
Range $80.00 – $130.00
+6.8%
Consensus $111.82 vs current $104.74